Antonella is the Chief Executive Officer. She was one of the founders of Okairos Srl.
Previously, Antonella was Group Leader at IRBM, where she focused her research interest in the field of diagnosis and prevention of chronic infectious diseases. Antonella conducted post‐doctoral studies in immunology at the Institute of Genetics and Molecular and Cellular Biology (IGBMC) in Strasbourg, France. She received her degree in Biology and a PhD in Molecular and Cellular Biology from the University of Rome, La Sapienza.
Antonella has strong research experience in the field of gene delivery and immunological analysis in preclinical and clinical settings.
Antonella has authored several scientific publications on subjects including peptide phage display technology, immunology, viral infections and vaccines in leading journals such as Nature Medicine and New England Journal of Medicine.